James Wick

920 total citations
35 papers, 572 citations indexed

About

James Wick is a scholar working on Epidemiology, Economics and Econometrics and Nephrology. According to data from OpenAlex, James Wick has authored 35 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Economics and Econometrics and 8 papers in Nephrology. Recurrent topics in James Wick's work include Chronic Disease Management Strategies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). James Wick is often cited by papers focused on Chronic Disease Management Strategies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). James Wick collaborates with scholars based in Canada, United States and United Kingdom. James Wick's co-authors include Paul E. Ronksley, Marvin J. Fritzler, Amy Metcalfe, Braden Manns, Marcello Tonelli, Brenda R. Hemmelgarn, Michael Mähler, Murray Baron, Marie Hudson and Solène Tatibouet and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Journal of the American Society of Nephrology.

In The Last Decade

James Wick

32 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Wick Canada 12 146 132 114 92 84 35 572
Carole Ayav France 14 107 0.7× 297 2.3× 27 0.2× 30 0.3× 73 0.9× 55 660
Bénédicte Sautenet France 18 76 0.5× 263 2.0× 24 0.2× 44 0.5× 77 0.9× 74 860
Elena Zakharova Russia 12 96 0.7× 148 1.1× 28 0.2× 23 0.3× 43 0.5× 80 598
Monica Beaulieu Canada 13 60 0.4× 416 3.2× 86 0.8× 25 0.3× 71 0.8× 26 648
Zaki Morad Malaysia 15 66 0.5× 400 3.0× 22 0.2× 176 1.9× 55 0.7× 35 706
Catherine Wall Ireland 12 107 0.7× 493 3.7× 121 1.1× 198 2.2× 22 0.3× 31 876
Madhuri Kanitkar India 14 104 0.7× 231 1.8× 52 0.5× 40 0.4× 31 0.4× 60 600
F. Jarraya Tunisia 13 73 0.5× 267 2.0× 30 0.3× 22 0.2× 48 0.6× 45 613
Lynn Robertson United Kingdom 14 133 0.9× 285 2.2× 34 0.3× 15 0.2× 109 1.3× 25 943
Sohail Abdul Salim United States 15 61 0.4× 214 1.6× 27 0.2× 27 0.3× 49 0.6× 44 781

Countries citing papers authored by James Wick

Since Specialization
Citations

This map shows the geographic impact of James Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Wick more than expected).

Fields of papers citing papers by James Wick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Wick. The network helps show where James Wick may publish in the future.

Co-authorship network of co-authors of James Wick

This figure shows the co-authorship network connecting the top 25 collaborators of James Wick. A scholar is included among the top collaborators of James Wick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Wick. James Wick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wick, James, Daniel Bekele Ketema, Luke Buizen, et al.. (2025). Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset. The Lancet Regional Health - Western Pacific. 57. 101541–101541.
3.
Neuen, Brendon L., Min Jun, James Wick, et al.. (2023). Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data. The Lancet Regional Health - Western Pacific. 43. 100988–100988. 13 indexed citations
4.
Jun, Min, James Wick, Brendon L. Neuen, et al.. (2023). The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset. Kidney International Reports. 9(2). 312–322. 5 indexed citations
5.
Stewart, Andrew J., Scott B. Patten, Kirsten M. Fiest, et al.. (2022). 10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada. The Canadian Journal of Psychiatry. 67(9). 725–735. 3 indexed citations
6.
Wick, James, David J.T. Campbell, Finlay A. McAlister, et al.. (2022). Identifying subgroups of adult high-cost health care users: a retrospective analysis. CMAJ Open. 10(2). E390–E399. 7 indexed citations
7.
Harrison, Tyrone G., Brenda R. Hemmelgarn, Matthew T. James, et al.. (2021). Association of Kidney Function with Major Postoperative Events After Noncardiac Ambulatory Surgeries: A Population-Based Cohort Study. Journal of the American Society of Nephrology. 32(10S). 739–739. 3 indexed citations
8.
Harrison, Tyrone G., Paul E. Ronksley, Matthew T. James, et al.. (2021). Mortality and cardiovascular events in adults with kidney failure after major non-cardiac surgery: a population-based cohort study. BMC Nephrology. 22(1). 365–365. 4 indexed citations
9.
Quinn, Amity E., Paul E. Ronksley, Lauren Bresee, et al.. (2021). Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings. CJC Open. 3(6). 703–713. 6 indexed citations
10.
Harrison, Tyrone G., Paul E. Ronksley, Matthew T. James, et al.. (2021). POS-522 MORTALITY AND CARDIOVASCULAR EVENTS IN ADULTS WITH KIDNEY FAILURE AFTER MAJOR NON-CARDIAC SURGERY: A POPULATION-BASED COHORT STUDY. Kidney International Reports. 6(4). S227–S227. 2 indexed citations
11.
Ronksley, Paul E., James Wick, Reed F. Beall, et al.. (2021). 86Segmenting persistently high-cost individuals into actionable groups. International Journal of Epidemiology. 50(Supplement_1). 2 indexed citations
12.
Beall, Reed F., Paul E. Ronksley, James Wick, et al.. (2020). Comparing Onset of Biosimilar Versus Generic Competition in the United States. Clinical Pharmacology & Therapeutics. 108(6). 1308–1314. 7 indexed citations
13.
Bello, Aminu K., Paul E. Ronksley, Navdeep Tangri, et al.. (2019). Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study. Kidney International Reports. 4(4). 561–570. 56 indexed citations
14.
Leal, Jenine, John Conly, Robert G. Weaver, et al.. (2019). Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada. Infection Control and Hospital Epidemiology. 40(10). 1135–1143. 10 indexed citations
15.
Wick, James, Brenda R. Hemmelgarn, Braden Manns, et al.. (2017). Comparison of Methods to Define High Use of Inpatient Services Using Population‐Based Data. Journal of Hospital Medicine. 12(8). 596–602. 9 indexed citations
16.
Wick, James, Tanvir Chowdhury Turin, Peter Faris, et al.. (2016). A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults. American Journal of Kidney Diseases. 69(5). 568–575. 49 indexed citations
17.
Schmeling, Heinrike, Michael Mähler, Deborah M. Levy, et al.. (2015). Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls. The Journal of Rheumatology. 42(12). 2419–2426. 27 indexed citations
18.
Hudson, Marie, Solène Tatibouet, James Wick, et al.. (2014). Clinical and Serologic Correlates of Anti‐PM/Scl Antibodies in Systemic Sclerosis: A Multicenter Study of 763 Patients. Arthritis & Rheumatology. 66(6). 1608–1615. 69 indexed citations
19.
Mähler, Michael, Minoru Satoh, Marie Hudson, et al.. (2014). Autoantibodies to the Rpp25 Component of the Th/To Complex are the Most Common Antibodies in Patients with Systemic Sclerosis without Antibodies Detectable by Widely Available Commercial Tests. The Journal of Rheumatology. 41(7). 1334–1343. 25 indexed citations
20.
Mähler, Michael, Liam Martin, Susan G. Barr, et al.. (2014). Clinical and Serological Features of Patients Referred through a Rheumatology Triage System because of Positive Antinuclear Antibodies. PLoS ONE. 9(4). e93812–e93812. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026